Intelligent Bio Solutions Inc.

Stay Updated with the Latest Intelligent Bio Solutions Inc. INBS News in Real Time

Find INBS news now at Meyka AI. Stay informed with the latest Intelligent Bio Solutions Inc. stocks updates, including price news, market analysis, and expert insights.

INBSNASDAQ
HealthcareMedical - Diagnostics & Research
$2.16
$0.09(4.00%)
U.S. Market is Open · 15:27
Nvidia (NASDAQ: NVDA) Partners With Fanuc and Yaskawa to Accelerate AI-Powered Robotics Development
📅 6 hours ago

Nvidia (NASDAQ: NVDA) Partners With Fanuc and Yaskawa to Accelerate AI-Powered Robotics Development

Nvidia confirmed Thursday, July 16, 2026, that it’s partnering with Japanese robotics giants Fanuc and Yaskawa Electric to accelerate AI-powered robotics development. CEO Jensen Huang announced at a media event in Tokyo, framing physical AI as the technology’s next major frontier. The move expands Nvidia’s Cosmos Coalition, a growing alliance built around its robotics software…

Read more 12
Hardee’s Franchisee Files Chapter 11 as 59 Stores Face Closure Risk
📅 11 hours ago

Hardee’s Franchisee Files Chapter 11 as 59 Stores Face Closure Risk

Hardee’s franchisee Superior Star files Chapter 11 bankruptcy on July 9, putting 59 stores at risk across 10 states due to a $7.04 million seller financing dispute and hidden liabilities from its 2023 acquisition.

Read more 12
DeepSeek Seeks Fresh Funding at $74 Billion Valuation Ahead of Planned China IPO
📅 1 day ago

DeepSeek Seeks Fresh Funding at $74 Billion Valuation Ahead of Planned China IPO

DeepSeek is back in the spotlight after reports said it is seeking fresh funding at a valuation of 500 billion yuan (about $74 billion) before a planned initial public offering (IPO) in China. The fundraising effort, reported on July 15, 2026, reflects rising investor interest in the country’s fast-growing artificial intelligence industry. As global competition…

Read more 12
Domino’s Pizza Reshapes Board with New Directors, Barry Named Lead Independent Director
📅 1 day ago

Domino’s Pizza Reshapes Board with New Directors, Barry Named Lead Independent Director

Domino’s Pizza adds Michael Creedon and Anneliese Olson to its board and names Corie Barry as lead independent director. The moves strengthen oversight and bring retail and technology expertise.

Read more 12
Mowi (OSE: MOWI) Shares Rise 3.4% as Q2 Salmon Harvest Tops Guidance and EBIT Climbs 23%
📅 1 day ago

Mowi (OSE: MOWI) Shares Rise 3.4% as Q2 Salmon Harvest Tops Guidance and EBIT Climbs 23%

Mowi shares rose 3.4% Wednesday after the salmon farmer’s Q2 trading update beat expectations. Mowi reported operational EBIT of EUR 231 million, up 23% from EUR 189 million. The company harvested 150,000 tonnes during the quarter, a record for any second quarter. That volume topped Mowi’s own guidance of 140,000 tonnes by a wide margin. …

Read more 12
Thames Water Swings to £226 Million Profit While Debt Climbs Close to £20 Billion
📅 1 day ago

Thames Water Swings to £226 Million Profit While Debt Climbs Close to £20 Billion

Thames Water swung to a £226.4 million pre-tax profit for the year ended March 31, 2026. That marks a dramatic turnaround from losses of £1.65 billion the previous year. Despite the profit swing, Thames Water’s total debt climbed to £19.77 billion. That’s up from £17.73 billion a year earlier, as the company kept borrowing.  Thames…

Read more 12
XRP Rallies 4.7% to $1.1105 After Ripple Joins UK Tokenization Taskforce
📅 1 day ago

XRP Rallies 4.7% to $1.1105 After Ripple Joins UK Tokenization Taskforce

XRP climbed 4.7% to $1.1105 on news that Ripple joined HM Treasury’s 54-firm tokenization initiative targeting £33B in UK economic output.

Read more 12
Vossloh (ETR: VOS) Stock Slides 9.71% as Company Lowers 2026 Revenue Forecast to €1.51B–€1.61B
📅 2 days ago

Vossloh (ETR: VOS) Stock Slides 9.71% as Company Lowers 2026 Revenue Forecast to €1.51B–€1.61B

Vossloh shares slid sharply Monday after the German rail supplier cut its 2026 outlook. The stock dropped as much as 9.71% following the guidance revision. Vossloh now expects 2026 revenue between €1.51 billion and €1.61 billion. That’s down from its prior forecast of €1.56 billion to €1.66 billion.  The company also trimmed its EBITDA and…

Read more 12
Biocon (NSE: BIOCON) Shares Jump 8.04% to 52-Week High After ₹400 Block Deal
📅 2 days ago

Biocon (NSE: BIOCON) Shares Jump 8.04% to 52-Week High After ₹400 Block Deal

On July 14, 2026, Biocon (NSE: BIOCON) shares climbed 8.04% to a fresh 52-week high after reports of a ₹400-per-share block deal involving a large institutional shareholder. The news led to heavy trading and renewed interest in one of India’s leading biopharmaceutical companies. Large block deals often raise questions about changes in ownership, but they…

Read more 12

INBS News FAQ